Iovance Biotherapeutics Inc
Statements
Ratios
Valuation ratios (P/E, P/S, EV/EBITDA and the other multiples) are based on the closing price at the end of each period, not on the current price. Margins and returns are shown in percent, multiples without a unit, per-share figures in the reporting currency, net debt in millions.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||||||||||||||||||||||||||||||||||
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 240,979,340,000.0 | 339,861,440,000.0 | 233,581,450,000.0 | 199,876,300,000.0 | – | – | – | – | – | – | – | 6,602.4 | 1,599.4 | 1,743.7 | 2,069.4 | 69.5 | 31.4 | 13.8 | 5.0 | 2.4 | 3.2 | 4.2 | 5.1 | 5.8 | |
| 2.7 | 2.6 | 3.1 | 3.6 | 3.0 | 4.0 | 4.9 | 4.3 | 4.2 | 2.3 | 2.7 | 7.6 | 6.4 | 11.7 | 15.6 | 4.8 | 6.8 | 10.4 | 7.2 | 5.4 | 5.5 | 4.8 | 4.8 | 3.7 | 3.8 | 2.1 | 2.0 | 2.7 | 1.7 | 3.5 | 5.8 | 3.0 | 3.7 | 3.2 | 1.4 | 0.8 | 1.1 | 1.6 | 2.0 | 2.6 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 237,923,640,000.0 | 336,809,190,000.0 | 227,329,550,000.0 | 196,009,550,000.0 | – | – | – | – | – | – | – | 5,685.8 | 1,236.9 | 1,654.4 | 2,005.2 | 62.9 | 29.7 | 13.1 | 4.2 | 1.8 | 2.6 | 3.6 | 4.5 | 5.5 | |
| -5.8% | -7.9% | -10.5% | -13.6% | -14.5% | -13.7% | -5.5% | -7.3% | -8.5% | -9.7% | -9.8% | -4.1% | -6.2% | -4.7% | -5.3% | -5.7% | -4.6% | -3.7% | -5.5% | -7.0% | -7.6% | -8.9% | -10.6% | -17.1% | -19.4% | -29.7% | -25.6% | -22.6% | -33.4% | -18.5% | -10.3% | -17.6% | -13.1% | -16.1% | -32.6% | -56.9% | -43.9% | -30.6% | -20.8% | -15.7% | |
| Margins | ||||||||||||||||||||||||||||||||||||||||
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -7,738.7% | -2,416.8% | -1,283.7% | -846.2% | -44.4% | 8.8% | 24.4% | 21.7% | 20.6% | 38.8% | 97.2% | 114.5% | 116.3% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -1,292,565,000,000.0% | -1,309,685,000,000.0% | -1,333,485,000,000.0% | -1,422,480,000,000.0% | – | – | – | – | – | – | – | -179,988.7% | -63,131.4% | -38,735.0% | -24,549.6% | -1,401.4% | -473.2% | -240.9% | -187.5% | -170.0% | -166.3% | -153.1% | -127.2% | -92.7% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -1,273,760,000,000.0% | -1,297,905,000,000.0% | -1,327,175,000,000.0% | -1,418,840,000,000.0% | – | – | – | – | – | – | – | -175,981.1% | -61,241.4% | -37,345.4% | -23,615.7% | -1,343.3% | -451.3% | -226.8% | -176.5% | -161.4% | -158.8% | -148.4% | -123.9% | -89.1% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -1,115,730,000,000.0% | -1,259,625,000,000.0% | -1,295,460,000,000.0% | -1,405,530,000,000.0% | – | – | – | – | – | – | – | -149,025.2% | -53,366.9% | -32,305.3% | -21,275.3% | -1,222.0% | -411.7% | -221.9% | -163.4% | -134.0% | -140.5% | -127.6% | -106.8% | -91.2% | |
| Returns | ||||||||||||||||||||||||||||||||||||||||
| -25.4% | -31.7% | -44.5% | -60.8% | -49.5% | -63.3% | -33.5% | -38.9% | -46.0% | -26.5% | -30.8% | -38.0% | -46.9% | -66.1% | -94.6% | -32.4% | -35.8% | -39.5% | -41.0% | -38.1% | -44.6% | -55.1% | -64.9% | -79.6% | -99.0% | -79.2% | -61.7% | -72.4% | -64.2% | -76.0% | -66.1% | -57.3% | -53.0% | -52.4% | -48.9% | -55.8% | -56.6% | -56.0% | -49.0% | -39.3% | |
| -25.0% | -30.8% | -42.9% | -56.9% | -47.1% | -59.3% | -31.9% | -36.9% | -43.1% | -25.7% | -29.0% | -34.6% | -42.1% | -57.3% | -79.8% | -30.0% | -32.6% | -33.8% | -35.4% | -33.3% | -37.6% | -44.0% | -51.1% | -61.6% | -71.4% | -59.6% | -49.9% | -55.3% | -50.8% | -56.9% | -51.7% | -45.7% | -41.4% | -40.9% | -38.8% | -43.0% | -43.9% | -42.8% | -38.2% | -31.6% | |
| Balance Sheet & Debt | ||||||||||||||||||||||||||||||||||||||||
| -93 | -166 | -147 | -114 | -163 | -145 | -297 | -246 | -81 | – | -44 | -69 | -31 | -6.7 | -46 | -155 | -61 | -61 | -125 | -77 | -51 | -72 | -84 | -101 | -110 | -218 | -530 | -218 | -256 | -106 | -122 | -216 | -152 | -102 | -162 | -124 | -151 | -159 | -193 | -108 | |
| 98.2% | 97.1% | 96.5% | 93.6% | 95.1% | 93.6% | 95.2% | 95.0% | 93.8% | 97.0% | 94.2% | 91.2% | 89.7% | 86.7% | 84.4% | 92.8% | 91.0% | 85.4% | 86.3% | 87.3% | 84.3% | 80.0% | 78.7% | 77.4% | 72.1% | 75.2% | 80.9% | 76.4% | 79.1% | 74.9% | 78.2% | 79.7% | 78.0% | 78.0% | 79.4% | 77.0% | 77.6% | 76.5% | 78.0% | 80.4% | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | – | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Per Share | ||||||||||||||||||||||||||||||||||||||||
| -0.77 | -0.85 | -1.07 | -1.26 | -1.29 | -1.26 | -1.16 | -1.17 | -1.23 | -1.04 | -1.09 | -1.22 | -1.34 | -1.56 | -1.82 | -1.84 | -1.74 | -1.77 | -1.80 | -1.85 | -2.00 | -2.18 | -2.28 | -2.39 | -2.47 | -2.40 | -1.93 | -1.87 | -1.76 | -1.73 | -1.69 | -1.55 | -1.35 | -1.22 | -1.16 | -1.17 | -1.09 | -0.96 | -0.85 | -0.64 | |
| 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.12 | 0.30 | 0.54 | 0.66 | 0.72 | 0.69 | 0.65 | 0.68 | 0.72 | |
| 3.03 | 2.69 | 2.41 | 2.07 | 2.61 | 2.00 | 3.47 | 3.00 | 2.67 | 3.91 | 3.52 | 3.22 | 2.86 | 2.37 | 1.92 | 5.69 | 4.86 | 4.48 | 4.39 | 4.84 | 4.49 | 3.96 | 3.51 | 3.01 | 2.49 | 3.03 | 3.12 | 2.58 | 2.74 | 2.28 | 2.55 | 2.70 | 2.55 | 2.33 | 2.38 | 2.09 | 1.93 | 1.72 | 1.72 | 1.63 | |
| -0.47 | -0.55 | -0.79 | -1.01 | -1.13 | -1.10 | -0.92 | -0.94 | -0.96 | -0.86 | -0.93 | -1.01 | -1.13 | -1.31 | -1.59 | -1.56 | -1.52 | -1.72 | -1.76 | -1.83 | -1.87 | -1.69 | -1.77 | -1.88 | -1.86 | -1.90 | -1.56 | -1.58 | -1.53 | -1.50 | -1.52 | -1.41 | -1.23 | -1.19 | -1.08 | -0.97 | -0.97 | -0.83 | -0.73 | -0.66 | |
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.